This is a Scorecard review, revisiting a past LF0 research call against what actually happened.
Ticker: STXS Rating: Sell Published: 2026-08-16 Checkpoint: 2026-11-16 Entry price: $1.39 Latest price: $0.84 as of 2026-11-13 Stock return since entry: -39.6% Signal return: +39.6% Verdict: Correct so far
This is the 3-month checkpoint for this call. LF0 publishes monthly Scorecard updates through month 6, using the closest available daily close on or before the checkpoint date.
Previous checkpoint: our 2-month review (2026-10-16) was correct (stock return -27.3% since entry). Each monthly review is judged on its own date, so the verdict can change from one month to the next.
Read the original LF0 analysis
What I Said
I argued that STXS was still a Sell because the business was burning cash, with $-8.8M of levered free cash flow over the trailing twelve months, while revenue remained uneven and the stock was already priced at 4.6x EV/Revenue. I also pointed to the tension between a 55.6% gross margin and a still-fragile operating base, and said I would become more constructive only if Q2 2026 revenue got back above $8.8M and free cash flow improved.
Peer Comparison
| Company | Return Since Entry |
|---|---|
| STXS (this call) | -39.6% |
| AORT | -33.5% |
| ATRC | +27.0% |
| PEN | -1.8% |
| RBOT | -93.8% |
| TCMD | +9.2% |
How Other Analysts Rate It
Every Wall Street rating action logged on Yahoo Finance since our Sell on 2026-08-17, one row per action (a firm that updates three times appears three times). LF0 rows are in bold.
| Date | Firm | Rating | Action | Price target |
|---|---|---|---|---|
| 2026-08-17 | LF0 Equity Research | Sell | Original call at $1.39 | |
| 2026-08-27 | Citizens | Market Outperform | Reiterated | $3.00 (from $4.00) |
| 2026-09-16 | LF0 Equity Research | Sell | 1-month update | |
| 2026-10-16 | LF0 Equity Research | Sell | 2-month update | |
| 2026-11-11 | TD Cowen | Buy | Reiterated | $2.00 (from $3.00) |
| 2026-11-16 | LF0 Equity Research | Sell | 3-month update (this report) |
No analyst changed their rating on this stock since our Sell on 2026-08-17; the table shows reiterations and price-target changes only.
2 firms still Buy-rated against our call at their latest action: Citizens and TD Cowen.
Counting each firm’s latest action in this window: 2 bullish, 0 neutral, 0 bearish out of 2 firms.
Source: Yahoo Finance analyst rating actions. Dates are when Yahoo logged the action. Analyst ratings are third-party opinions, not LF0 views or recommendations.
Why It’s Working (Or Not)
Over this tracking window, following the Sell would have earned 39.6%, which means the bearish call has been rewarded. The stock has fallen from my entry price, and that move lines up with the original concern that the company was not yet self-funding despite a respectable gross margin. The peer set has been mixed, with several comparables also lower but others higher, so STXS has not simply moved with the group; it has still delivered the downside I was looking for from the short side. The specific risk I highlighted — persistent cash burn against a rich revenue multiple — has remained the right lens for the call.
What Could Still Prove Me Wrong
If STXS reclaims the revenue level I flagged and shows that Q2 2026 revenue is back above $8.8M, that would weaken the case that the business is stuck below a sustainable run rate. I would also reconsider if free cash flow turns positive, because that would directly challenge my view that the company is still funding itself through external capital rather than operating cash generation. A sustained improvement in operating margin would be another clear sign that gross profit is finally covering the cost structure.
The August 2026 Cohort
Other directional calls published the same month:
| Ticker | Rating | Entry | Latest | Stock Return | Signal Return | Verdict |
|---|---|---|---|---|---|---|
| SDGR | Sell | $17.40 | $29.53 | +69.7% | -69.7% | Incorrect so far |
| GTN | Sell | $4.83 | $5.99 | +24.0% | -24.0% | Incorrect so far |
| NUTX | Buy | $188.41 | $173.67 | -7.8% | -7.8% | Incorrect so far |
| LHX | Sell | $260.92 | $272.35 | +4.4% | -4.4% | Incorrect so far |
| VNOM | Sell | $41.16 | $42.34 | +2.9% | -2.9% | Incorrect so far |
| AES | Sell | $14.54 | $14.91 | +2.6% | -2.6% | Incorrect so far |
| PENN | Sell | $18.56 | $17.50 | -5.7% | +5.7% | Correct so far |
| RRGB | Sell | $9.51 | $8.81 | -7.4% | +7.4% | Correct so far |
| SPHR | Sell | $147.34 | $125.56 | -14.8% | +14.8% | Correct so far |
| BA | Sell | $210.46 | $171.50 | -18.5% | +18.5% | Correct so far |
| NNDM | Sell | $1.65 | $1.24 | -24.8% | +24.8% | Correct so far |
| NXE | Sell | $10.40 | $7.76 | -25.4% | +25.4% | Correct so far |
| OI | Sell | $6.79 | $4.96 | -27.0% | +27.0% | Correct so far |
| WGS | Sell | $77.88 | $52.37 | -32.8% | +32.8% | Correct so far |
| LRCX | Sell | $343.48 | $225.92 | -34.2% | +34.2% | Correct so far |
| ADTN | Sell | $7.76 | $4.83 | -37.8% | +37.8% | Correct so far |
| OWLT | Sell | $5.81 | $3.44 | -40.8% | +40.8% | Correct so far |
| SRG | Strong Sell | $2.11 | $1.52 | -28.0% | +41.9% | Correct so far |
Sector Scorecard: Healthcare
How are our Healthcare calls doing overall, and where does STXS sit among them?
| Peer call | Rating | Published | Signal return |
|---|---|---|---|
| OWLT | Sell | 2026-08-12 | +40.8% |
| CUE | Sell | 2026-09-02 | +40.2% |
| WGS | Sell | 2026-08-09 | +32.8% |
| CRSP | Strong Sell | 2026-10-26 | +20.7% |
| ABCL | Strong Sell | 2026-11-09 | +12.1% |
| BFLY | Strong Sell | 2026-11-02 | +1.5% |
| BSX | Buy | 2026-06-14 | -5.1% |
| NUTX | Buy | 2026-08-16 | -7.8% |
We saw Technology lead the league table with a 92% hit rate and +27.9% average signal return, while Industrials followed at 81% and +21.4%. Healthcare sat in the middle of the pack with 12 calls, a 58% hit rate, and +6.3% average signal return, with OWLT +40.8% as the best call and SDGR -69.7% as the worst. Thin sectors were not ranked, and the thin groups in the file were Real Estate (2 calls), Consumer Defensive (1 calls), and Unclassified (2 calls).
Sector League Table
| Sector | Calls | Hit rate | Avg signal return | Best | Worst |
|---|---|---|---|---|---|
| Technology | 25 | 92% | +27.9% | CIFR +68.6% | NLST -107.0% |
| Industrials | 16 | 81% | +21.4% | BW +74.3% | LUNR -35.4% |
| Financial Services | 5 | 100% | +18.9% | HUT +41.5% | BMNR +0.9% |
| Utilities | 3 | 33% | +17.2% | FLNC +67.5% | TLN -13.3% |
| Basic Materials | 5 | 80% | +14.1% | LAR +45.1% | MP -5.2% |
| Consumer Cyclical | 4 | 100% | +10.3% | OI +27.0% | FLUT +1.2% |
| Energy | 6 | 67% | +9.4% | BORR +23.0% | SM -18.9% |
| Healthcare | 12 | 58% | +6.3% | OWLT +40.8% | SDGR -69.7% |
| Communication Services | 5 | 60% | +4.1% | LUMN +39.7% | GTN -24.0% |
| Real Estate* | 2 | 50% | +10.6% | SRG +41.9% | SKYH -20.7% |
| Consumer Defensive* | 1 | 0% | -1.6% | PG -1.6% | PG -1.6% |
| Unclassified* | 2 | 50% | -7.6% | NXE +25.4% | FISV -40.5% |
\* Fewer than 3 calls: not ranked.
Sector by Publish Month
| Sector | Jun 2026 | Jul 2026 | Aug 2026 | Sep 2026 | Oct 2026 | Nov 2026 |
|---|---|---|---|---|---|---|
| Technology | +51.5% (2) | +12.1% (7) | +32.3% (3) | +30.2% (6) | +33.1% (7) | — |
| Industrials | +74.3% (1) | +43.7% (5) | +7.1% (2) | +8.8% (3) | +4.3% (3) | -1.8% (2) |
| Healthcare | -5.1% (1) | — | +7.1% (5) | +40.2% (1) | -2.9% (3) | +6.8% (2) |
| Energy | — | +19.1% (1) | -2.9% (1) | +23.0% (1) | +5.8% (3) | — |
| Communication Services | — | +8.0% (1) | -4.6% (2) | -17.7% (1) | +39.7% (1) | — |
| Financial Services | — | +27.5% (3) | — | — | +8.4% (1) | +3.8% (1) |
| Basic Materials | — | +1.8% (1) | — | +45.1% (1) | +14.4% (2) | -5.2% (1) |
| Consumer Cyclical | — | — | +13.3% (3) | — | — | +1.2% (1) |
| Utilities | — | +67.5% (1) | -2.6% (1) | — | -13.3% (1) | — |
| Unclassified | — | — | +25.4% (1) | — | -40.5% (1) | — |
| Real Estate | -20.7% (1) | — | +41.9% (1) | — | — | — |
| Consumer Defensive | — | — | — | — | — | -1.6% (1) |
Each cell: average signal return to date of the calls published that month (calls in brackets). Signal return is direction-adjusted, so a positive number means our call is right.
Live LF0 scorecard: The Scorecard | Research Performance dashboard
Past performance does not guarantee future results. Nothing here is investment advice or a recommendation to buy or sell securities. Returns use LF0’s daily-close scorecard methodology.
Leave a Comment